Table 2 |
||||
|
Hemodynamics in the treatment model |
||||
|
Systolic blood pressure |
Heart rate |
|||
|
|
||||
|
Group |
Baseline |
4 hours |
Baseline |
4 hours |
|
|
||||
|
Control |
125 ± 6 |
88 ± 6 |
425 ± 25 |
327 ± 9 |
|
LPS alone |
98 ± 8 |
70 ± 5 |
465 ± 11 |
438 ± 28* |
|
LPS + 0.025% of 1,600 kDa HMW HA |
125 ± 5 |
72 ± 8 |
442 ± 21 |
448 ± 9* |
|
LPS + 0.5% of 1,600 kDa HMW HA |
112 ± 9 |
86 ± 6 |
475 ± 17 |
445 ± 10* |
|
LPS + 0.1% of 1,600 kDa HMW HA |
97 ± 16 |
87 ± 6 |
495 ± 18 |
401 ± 23* |
|
LPS + 0.1% sodium carboxymethyl cellulose |
97 ± 8 |
85 ± 7 |
464 ± 18 |
474 ± 30* † |
|
|
||||
|
There were no statistical differences between groups for systolic blood pressure. In the lipopolysaccharide (LPS)-exposed groups the heart rate was statistically higher, but there were no statistical differences between the high-molecular-weight hyaluronan (HMW HA) treatment groups. LPS + 0.1% sodium carboxymethyl cellulose was statistically higher than LPS + 0.1% HMW HA. *P < 0.01 versus control. †P < 0.01 versus LPS + 0.1% HMW HA. |
||||
|
Liu et al. Critical Care 2008 12:R102 doi:10.1186/cc6982 |
||||